Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

研究方向

Immunology/Inflammation 相关产品(4245)

  • GC63151 structure
    GC63151POT-4
    CAS: 934461-40-2
    纯度: >99.50%

    POT-4 (AL-78898A),一种 Compstatin 衍生物,是补体因子 C3 激活的有效抑制剂。POT-4 可用于与年龄相关的黄斑变性的研究。

  • GC63197 structure
    GC63197Sonlicromanol
    CAS: 1541170-75-5

    Sonlicromanol (KH176) 是具有口服活性的活性氧 (ROS) 的调节剂。可用于线粒体疾病的研究。

  • GC63198 structure
    GC63198Sonlicromanol hydrochloride
    CAS: 2162149-24-6
    纯度: >99.50%

    Sonlicromanol (KH176) hydrochloride 是 Trolox 的衍生物,是可透过血脑屏障的 ROS-redox 调节剂。Sonlicromanol (KH176) hydrochloride 可用于线粒体相关疾病研究。

  • GC63202 structure
    GC63202SSK1
    CAS: 2629250-69-5
    纯度: >99.00%

    SSK1,是一种衰老特异性杀伤化合物,是一种 β-galactosidase 靶向前药,可减轻炎症。SSK1 被溶酶体 β-galactosidase 激活,并通过激活 p38 MAPK 和诱导细胞凋亡 (apoptosis) 选择性杀死衰老细胞。

  • GC63212 structure
    GC63212TBK1/IKKε-IN-4
    CAS: 1381930-17-1
    纯度: >98.50%

    TBK1/IKKε-IN-4 是一种 6-氨基吡唑并嘧啶衍生物,也是一种有效的,选择性的 TBK1 和 IKKε 抑制剂,IC50 值分别为 13 nM 和 59 nM。TBK1/IKKε-IN-4 对其他蛋白质激酶(包括 PDK1,PI3K 家族成员和 mTOR)的活性降低了 100-1000 倍。

  • GC63301 structure
    GC63301AWL-II-38.3
    CAS: 1135205-94-5
    纯度: >97.00%

    AWL-II-38.3 is a potent Ephrin type-A receptor 3 (EphA3) kinase inhibitor.

  • GC63323 structure
    GC63323Pirepemat
    CAS: 1227638-29-0
    纯度: >98.50%

    Pirepemat (IRL752) 是一种儿茶酚胺和认知促进剂。 Pireemat (IRL752) 可用于帕金森病的研究。

  • GC63324 structure
    GC63324Rimsulfuron
    CAS: 122931-48-0
    纯度: >96.00%

    Rimsulfuron (DPX-E9636) 是一种磺酰脲类除草剂,在玉米出苗后用于控制禾草和一些阔叶杂草。

  • GC63339 structure
    GC63339OSBPL7-IN-1
    CAS: 1269826-44-9

    OSBPL7-IN-1 是一种具有口服活性的氧甾醇结合蛋白样 7 (OSBPL7) 抑制剂。OSBPL7-IN-1 促进质膜上 ABCA1 的增加而不影响 mRNA 表达。

  • GC63341 structure
    GC63341Odoroside A
    CAS: 12738-19-1

    Odoroside A 是从夹竹桃叶中提取的一种有效成分。Odoroside A 具有抗癌活性。Odoroside A 通过 ROS/p53 信号通路诱导细胞凋亡和细胞周期阻滞,导致肿瘤细胞死亡。

  • GC63344 structure
    GC63344PFM39
    CAS: 1310744-67-2
    纯度: >98.00%

    PFM39 是一种 Mirin 类似物,是一种有效的选择性 MRE11 核酸外切酶抑制剂。PFM39 阻断 dsDNA 磷酸骨架的旋转,但不抑制 TmMre11 或人类 MRE11/MRN 核酸内切酶活性。

  • GC63347 structure
    GC63347Peptide 78
    CAS: 132116-62-2

    Peptide 78,一种趋化细胞因子,由 78 个氨基酸组成,是 IL-8 或 C-X-C 趋化因子超基因家族的蛋白成员。Peptide 78 诱导中性粒细胞 (PMN) 在类风湿性关节炎 (RA) 关节方面发挥重要作用。

  • GC63361 structure
    GC63361CR-1-30-B
    CAS: 1352914-53-4
    纯度: >99.50%

    CR-1-30-B 是 CR-1-31-B 的一种非活性对映体。作为对照,CR-1-30-B 对 eIF4A 不起作用,并且对 MUC1-C 翻译的诱导没有明显影响。

  • GC63364 structure
    GC63364DB2115 tertahydrochloride
    CAS: 1366126-19-3
    纯度: >99.00%

    DB2115 (tertahydrochloride) 是骨髓主调节因子 PU.1 的有效抑制剂。DB2115 (tertahydrochloride) 具有治疗癌症的潜力,包括白血病等血液系统癌症,以及与PU. 1 功能障碍相关的其他疾病 (信息来自专利 WO2017223260A1,compound DB2115)。

  • GC63368 structure
    GC63368Patisiran sodium
    CAS: 1386913-72-9
    纯度: >99.00%

    Patisiran sodium 是一种双链小干扰 RNA,靶向 Transthyretin (TTR) 信使 RNA 内的序列。Patisiran sodium 特异性抑制突变体和野生型 TTR 的肝脏合成。Patisiran sodium 可用于研究遗传性 TTR 淀粉样蛋白症的研究。

  • GC63377 structure
    GC63377QS-21
    CAS: 141256-04-4
    纯度: >90.00% / >98.00% / >99.00%

    QS-21是一种免疫刺激性皂苷,可用作有效的疫苗佐剂。

  • GC63379 structure
    GC63379Conophylline
    CAS: 142741-24-0

    Conophylline 是一种从热带植物 Ervatamia microphylla 中提取的长春花生物碱。Conophylline 是胰腺细胞分化的诱导剂。Conophylline 能抑制 HSC,诱导其凋亡。

  • GC63386 structure
    GC63386Isatuximab
    CAS: 1461640-62-9

    Isatuximab (anti-CD38) (SAR650984, hu38SB19) is an IgG1-derived monoclonal antibody that binds to a specific extracellular epitope of CD38 receptor with a kd of 0.12 nM.

  • GC63393 structure
    GC63393Citronellyl acetate
    CAS: 150-84-5
    纯度: >99.00%

    Citronellyl acetate (Citronellol acetate) is a natural flavouring ingredient.

  • GC63394 structure
    GC63394Zaloglanstat
    CAS: 1513852-12-4

    Zaloglanstat (ISC-27864) 是 mPGES-1 的抑制剂,可用于哮喘、骨关节炎、类风湿性关节炎、急性或慢性疼痛和神经退行性疾病等的研究。

  • GC63401 structure
    GC63401BPH-652
    CAS: 157124-84-0
    纯度: >98.50%

    BPH-652 是 CrtM 的抑制剂,Ki 值为 1.5 nM,IC50 值为100-300 nM (S. aureus 色素形成)。

  • GC63409 structure
    GC63409SG3199-Val-Ala-PAB
    CAS: 1595275-61-8

    SG3199-Val-Ala-PAB 是 Tesirine 合成的中间体。Tesirine 是一种用于抗体偶联药物 (ADC) 的药物-linker 连接物,能用于多种癌症的研究。

  • GC63420 structure
    GC63420ABR-238901
    CAS: 1638200-22-2
    纯度: >99.00% / >98.00%

    ABR-238901是S100A8/A9阻断剂,有效抑制了S100A8/A9与高级糖基化终产物受体(RAGE)以及Toll样受体4(TLR4)之间的相互作用。

  • GC63424 structure
    GC63424Givosiran
    CAS: 1639325-43-1
    纯度: >97.50%

    Givosiran (ALN-AS1) 是一种小干扰 RNA,靶向肝脏氨基纤维素合酶 1 (ALAS1) 信使 RNA。Givosiran 下调 ALAS1 mRNA 并阻止神经毒性 δ-氨基纤维酸和卟啉的积累。Givosiran 可用于急性间歇性卟啉症的研究。